(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYAD

ST13

US500000079244095

Class

5, 10, 42

Filing

79244095

Registration

5847698

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

03/21/2026

Trademark type

Word

Nice classes

5, 10, 42

Filing date

06/19/2018

Registration date

09/03/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2026

Last transaction

03/21/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

BE

Examiner

MCDOWELL, MATTHEW J

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Celyad Oncology, Société anonyme
CELYAD

Representatives

Todd A. Denys Porzio, Bromberg & Newman, P.C.

Technical classification

Nice Classes

Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; implants comprised of living tissuesfor pharmaceutical use; pharmaceutical productsproducts for the treatment of tumors and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; compositions comprised of white blood cellsspecifically T-cells and NK-cellsfor pharmaceutical use; viral vectors in the nature of biological cultures for medical use; plasmids in the nature of DNA molecules for medical use

Class 10

Bioreactors for medical analysis; apparatus for cultureproliferation and modification of human cells for medical purposes; apparatus for cell therapy; catheters; surgical and medical instruments for use in the diagnosis and treatment of oncology and cardio-vascular diseases; medical implants consisting of artificial materials

Class 42

Scientific and technological servicesresearchanalysis and testing in the field of oncology and cardio-vascular diseases; scientific research services in the field of cell therapyoncologyimmuno-oncology and in the field of medical and surgical instruments

Publications

History of USPTO decisions and trademark events.

33 publications found

C71T

CANCELLED SECTION 71

03/20/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/21/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/13/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/03/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/20/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/13/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/24/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/04/2020

FIMP

FINAL DISPOSITION PROCESSED

01/04/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/03/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/03/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/18/2019

PUBO

PUBLISHED FOR OPPOSITION

06/18/2019

GPNX

NOTIFICATION PROCESSED BY IB

06/14/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/29/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/29/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/29/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/11/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/11/2019

ALIE

ASSIGNED TO LIE

05/08/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/07/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/03/2019

RFNT

REFUSAL PROCESSED BY IB

12/15/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/27/2018

RFRR

REFUSAL PROCESSED BY MPU

11/27/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/11/2018

CNRT

NON-FINAL ACTION WRITTEN

11/10/2018

MAFR

APPLICATION FILING RECEIPT MAILED

11/06/2018

DOCK

ASSIGNED TO EXAMINER

11/02/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/02/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/01/2018

Continuous trademark protection

Get notified about every new filing that threatens CYAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.